SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001654954-19-003863
Filing Date
2019-04-01
Accepted
2019-04-01 16:41:14
Documents
86
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT azrx10k_dec312018.htm 10-K 1542425
2 EXHIBIT 10.25 ex10-25.htm EX-10.25 268259
3 EXHIBIT 10.26 ex10-26.htm EX-10.26 135885
4 EXHIBIT 23 ex23.htm EX-23 4395
5 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ex31-1.htm EX-31.1 18691
6 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ex31-2.htm EX-31.2 223
7 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE ex32-1.htm EX-32 11812
  Complete submission text file 0001654954-19-003863.txt   4983084

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT azrx-20181231.xml EX-101.INS 644574
9 XBRL TAXONOMY EXTENSION SCHEMA azrx-20181231.xsd EX-101.SCH 60034
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE azrx-20181231_cal.xml EX-101.CAL 53737
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE azrx-20181231_def.xml EX-101.DEF 134202
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE azrx-20181231_lab.xml EX-101.LAB 302416
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE azrx-20181231_pre.xml EX-101.PRE 253544
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-K | Act: 34 | File No.: 001-37853 | Film No.: 19721282
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1